Covered recipient · General Payments record
HEATHER ROBINETTE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$463.47
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $300.63 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $50.60 | 3 |
| DEXCOM, INC. | $46.26 | 2 |
| CeQur Corporation | $36.92 | 1 |
| CHIESI USA, INC. | $33.21 | 1 |
| ABBVIE INC. | $19.60 | 1 |
| Novo Nordisk AS | $19.18 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.51 | 1 |
| Amneal Pharmaceuticals LLC | $17.11 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.65 | 1 |
| TheracosBio, LLC | $15.46 | 1 |
| IBSA Pharma Inc. | $14.40 | 1 |
| Amphastar Pharmaceuticals, Inc. | $13.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.60 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108098622 | CMS |
| Amneal Pharmaceuticals LLC | $17.11 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139215818 | CMS |
| Amphastar Pharmaceuticals, Inc. | $13.73 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149951970 | CMS |
| CeQur Corporation | $36.92 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099649787 | CMS |
| Chiesi USA, Inc. | $33.21 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151838341 | CMS |
| Dexcom, Inc. | $21.28 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153362598 | CMS |
| Dexcom, Inc. | $24.98 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153362600 | CMS |
| IBSA Pharma Inc. | $14.40 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142972255 | CMS |
| Lilly USA, LLC | $15.69 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135640648 | CMS |
| Lilly USA, LLC | $16.81 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135698578 | CMS |
| Lilly USA, LLC | $18.10 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135679197 | CMS |
| Novo Nordisk Inc | $19.18 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100309993 | CMS |
| SANOFI-AVENTIS U.S. LLC | $17.51 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139753431 | CMS |
| TheracosBio, LLC | $15.46 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148365991 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.65 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144627021 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.